Stock Watch: Biogen, Blood In The Water
The Acquisition Targets Of A Company In Trouble May Not Be Enthusiastic
When almost everything that could go wrong has gone wrong at a company, the proposition of it turning acquirer may meet with some resistance from its proposed targets and their investors.
